🔎 Trials Near Me

Gara Jalqabaatti › Glioma › North Carolina

Qorannoo klinikaalii Glioma North Carolina keessatti

Qorannoo 16 Glioma f North Carolina keessatti hirmaatuu jiru.

Magaalota North Carolina keessatti

Takkalaa qorannoo (Ingiliffa)

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

  • Novant Health Presbyterian Medical Center, Charlotte
  • East Carolina University, Greenville
  • Wake Forest University Health Sciences, Winston-Salem
Namoota walitti qabaa jiraSadarkaa 1/2
12 Months – 21 Years · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT05099003

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

  • Levine Children's Hospital- Pediatric Neuro-Oncology, Charlotte
Namoota walitti qabaa jiraSadarkaa 1/2
Hanga umuriin 25 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT04094610

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

  • Duke University Medical Center, Durham
Namoota walitti qabaa jiraSadarkaa 2
12 Months – 39 Years · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT06838676

Targeted Pediatric High-Grade Glioma Therapy

  • Duke University Health System, Durham
Namoota walitti qabaa jiraQorannoo ilaalaa
12 Months – 39 Years · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

  • Duke University Health System, Durham
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 12 hanga 39 · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

  • Duke Cancer Institute, Durham
  • Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT05303519

ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas

  • Duke University Medical Center, Durham
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Hag-2026 · NCT05609994

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

  • Duke Cancer Center, Durham
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 3 hanga 39 · Saalaa hunda · Haaromfame 24-Hag-2026 · NCT05096481

MRI in High-Grade Glioma Patients Undergoing Chemoradiation

  • Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT05212272

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • Atrium Health Wake Forest Baptist - Comprehensive Cancer Center, Winston-Salem
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 8 fi ol · Saalaa hunda · Haaromfame 27-Ado-2026 · NCT05503797

Lerapolturev (PVSRIPO) in GBM

  • Duke University Medical Center, Durham
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Ado-2026 · NCT06177964

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

  • Duke University Health System, Durham
Namoota walitti qabaa jiraSadarkaa jalqabaa 1Hojjettoota fayyaa simatamoo
Umuriin 1 hanga 21 · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT06333899

Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma

  • Duke University Medical Center, Durham
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Wax-2026 · NCT04547777

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

  • Duke University Health System, Durham
Namoota walitti qabaa jiraSadarkaa 2
12 Months – 39 Years · Saalaa hunda · Haaromfame 29-Cam-2026 · NCT05843253

Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252

  • Duke University, Durham
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Elb-2026 · NCT06126744

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

  • Duke University Health System, Durham
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
Hanga umuriin 21 · Saalaa hunda · Haaromfame 18-Bit-2026 · NCT04655404

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.